U.S. Markets close in 28 mins.

Innovus Pharmaceuticals, Inc. (INNV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.09203-0.00547 (-5.61025%)
As of 3:08PM EDT. Market open.
People also watch
IGXTPPCHCLRBIMNPSPHS
Full screen
Previous Close0.09750
Open0.10000
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.09170 - 0.10000
52 Week Range0.08200 - 0.39000
Volume432,468
Avg. Volume361,715
Market Cap13.92M
Beta3.83
PE Ratio (TTM)-1.07
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Innovus Pharmaceuticals, Inc. :INNV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube10 months ago

    Innovus Pharmaceuticals, Inc. :INNV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Innovus Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Innovus Pharmaceuticals, Inc. – Horizon Pharma plc, AcelRx Pharmaceuticals, Inc., Cambrex Corporation, Merck & Co., Inc. and Mylan N.V. (HZNP-US, ACRX-US, CBM-US, MRK-US and MYL-US) that have also ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.